| LEUKEMIA 360 is back with its 3rd edition ! November 17, 2026 VERSO Conference Center, 52 Rue de la Victoire, 75009 Paris, France |
| Next November 17, Institut Carnot OPALE, The Organization for Partnerships in Leukemia, will bring together key academic and industrial stakeholders to accelerate partnership-driven innovation in leukemia and related diseases. Designed as a one-day, high-level R&D&I international partnering event, LEUKEMIA 360 offers pharmaceutical, biotech, medtech, IVD, and investment companies direct access to leukemia KOLs and experts. Meet them and discuss how to accelerate your leukemia innovation market access together. Why attend LEUKEMIA 360?➡️ A single scope: adult and pediatric leukemia and related diseases (AML, ALL, CML, MDS, MPS, etc)➡️ Partnership-ready assets: patents, plaforms, models, labs, hospitals, databases, collections, observatories…➡️ Qualified interactions: targeted B2B meetings with leading researchers➡️ A trusted framework: Institut Carnot label, long-standing experience of public-private partnerships (around 800 clinical and non-clinical projects with close to 200 partners over past 5 years) LEUKEMIA 360 is not another scientific event.It is a science-backed strategic meeting point for those looking to identify collaboration opportunities, de-risk and accelerate innovation, and build meaningful R&D collaborations in the leukemia field. Program details will be announced shortly. 👉 Pre-register and get priority access to the meeting agenda and sponsoring opportunities |
